Hanmi Pharm. Co.

128940.KO

171.38 USD

-5.13

-2.91%

Overview

Last close

171.38 usd

Market cap

2.17B usd

52 week high

279.43 usd

52 week low

171.28 usd

Target price

260.21 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.9924

Price/Book Value

2.9726

Enterprise Value

2.44B usd

EV/Revenue

2.2427

EV/EBITDA

10.0519

Key financials

Revenue TTM

1.09B usd

Gross Profit TTM

608.48M usd

EBITDA TTM

253.24M usd

Earnings per Share

N/A usd

Dividend

0.52 usd

Total assets

1.49B usd

Net debt

N/A usd

About

Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is based in Hwaseong-si, South Korea.